Motiv8 Investments’s Argos Therapeutics, Inc. ARGS Stock Holding History

Motiv8 Investments’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$0	Buy	+40	New	–	﹤0.01%	1020

Motiv8 Investments's ARGS Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Argos Therapeutics, Inc. (ARGS) in Q4 2025: 40 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1020 among its holdings.

1 fund tracked by Wall St. Rank holds ARGS as of Q4 2025.

Motiv8 Investments held 40 shares of Argos Therapeutics, Inc. worth $0 as of Q4 2025.
Argos Therapeutics, Inc. was a new Motiv8 Investments position in Q4 2025.
Argos Therapeutics, Inc. made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #1020 holding.
1 fund tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.